Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Extracorporeal Membrane Oxygenation Complication peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Extracorporeal Membrane Oxygenation Complication. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
1 profiles.
2023–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 14 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Extracorporeal Membrane Oxygenation Complication unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT03318393
PeptideScanner retained ClinicalTrials.gov record NCT03318393 at 2026-11-15T21:58:19.888Z. Its registry update date was 2023-01-31, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- January 31, 2023
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05959252
PeptideScanner retained ClinicalTrials.gov record NCT05959252 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 8, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06275555
PeptideScanner retained ClinicalTrials.gov record NCT06275555 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-04-06, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 6, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Bivalirudin · 2026-05-08
ClinicalTrials.gov record NCT05959252
Recruiting at the retained observation.
Open attributed record →Bivalirudin · 2026-04-06
ClinicalTrials.gov record NCT06275555
Recruiting at the retained observation.
Open attributed record →Bivalirudin · 2023-01-31
ClinicalTrials.gov record NCT03318393
Completed at the retained observation.
Open attributed record →